Local Cdiff information for Florida
Florida
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Florida.
Local Cdiff information for Florida
Florida
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Florida.
Providers
Dr. Alison Schneider, MD
Cleveland Clinic Florida
2950 Cleveland Clinic Blvd
Weston, 33331
(954) 659-5646
FMT Provider: Yes
Dr. Lawrence Rothman, MD
Gastro Health
9408 SW 87th Ave, Suite 200
Miami, 33176
305-913-0666
FMT Provider: Yes
Dr. R. David Shepherd, MD
Florida Medical Clinic
4224 N Tampania Ave
Tampa, 33607
813-280-7111
FMT Provider: Yes
Dr. Katherine Kosche, MD, PhD
Gastro Health
12251 Taft Street
Suite 401
Pembroke Pines, 33026
(954) 433-5900
FMT Provider: Yes
Dr. Sovi Joseph, MD
Dr. Lawrence Fiedler, MD
Gastro Health
2300 Glades Road
Suite 201E
Boca Raton, 33431
(561) 208-2121
FMT Provider: Yes
Regulation
C. diff Infections
Total Reported Cases: 5269
Hospital Onset: 5269
Community Onset: Not reported
Related Deaths: Not reported
Available Reports
State Reporting Laws
Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
State Contact
A.C. (Anne-Carol) Burke, M.A.
Healthcare-associated Infection Prevention Program Manager
Florida Department of Health
Bureau of Epidemiology
4052 Bald Cypress Way
Tallahassee, 32399
850-766-7547
CLINICAL TRIALS
FMT National Registry
Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
Gender: All
Age: All ages
ROAR
Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.
LMN-201
Official Title: A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence
Trial No. NCT05330182
Type: Interventional
Recruitment: Recruiting
Sponsor: Lumen Bioscience, Inc.
Contact: Carl Mason, MD
Trial No. NCT05330182
Type: Interventional
Recruitment: Recruiting
Sponsor: Lumen Bioscience, Inc.
Contact: Carl Mason, MD
Gender: All
Age: 18 Years and older